Skin Therapy Letter

Articles Available on Medscape

• Utility of the Human Papillomavirus Vaccination in Management of HPV-associated Cutaneous Lesions
  Is there a role for the HPV vaccine in treating HPV-related dermatologic conditions such as common warts, genital warts, keratinocyte carcinoma, and epidermodysplasia verruciformis?

  June 18, 2021

• Certolizumab Pegol in Plaque Psoriasis: Considerations for Pregnancy
  Is the anti-tumor necrosis factor-alpha agent certolizumab pegol safe to use in pregnant patients? Review the latest data in this article.

  May 18, 2021

• Long-term Efficacy and Safety of Once-daily Efinaconazole 10% Topical Solution (Jublia) for Dermatophyte Toenail Onychomycosis
  This interim data indicates the effectiveness and safety of efinaconazole 10% solution use beyond 12 months. Use for up to 24 months appears to remain safe even for elderly patients.

  March 09, 2021

• Crisaborole 2% Ointment for Mild-to-Moderate Atopic Dermatitis
  Review current evidence for the use of crisaborole 2% ointment, a topical phosphodiesterase-4 inhibitor, for the treatment of atopic dermatitis.

  March 02, 2021

• Nicotinamide: An Update and Review of Safety & Differences From Niacin
  Nicotinamide, a form of vitamin B3, is an oral treatment option for actinic keratosis, squamous and basal cell carcinomas, and bullous pemphigoid. How does it relate to niacin--and how is it used?

  February 23, 2021

Table of Contents

2021 - 26 (1)

• Long-term Efficacy and Safety of Once-daily Efinaconazole 10% Topical Solution (Jublia) for Dermatophyte Toenail Onychomycosis: An Interim Analysis. 

  January 01, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Crisaborole 2% Ointment for Mild-to-Moderate Atopic Dermatitis. 

  January 01, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]